Emerging platinum(iv) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment

scientific article published on 01 February 2019

Emerging platinum(iv) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1039/C8DT03923B
P698PubMed publication ID30633263

P50authorZhiqin DengQ90680501
Zhigang WangQ90999758
P2093author name stringGuangyu Zhu
P433issue8
P921main subjectplatinumQ880
cisplatinQ412415
P304page(s)2536-2544
P577publication date2019-02-01
P1433published inDalton TransactionsQ282900
P1476titleEmerging platinum(iv) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment
P478volume48

Reverse relations

cites work (P2860)
Q99553693Co-drug delivery of regorafenib and cisplatin with amphiphilic copolymer nanoparticles: enhanced in vivo antitumor cancer therapy in nursing care
Q91710491The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents

Search more.